Anavex Life Sciences Corp (AVXL)

[georgejjl]

NEW PATENT APPLICATION TODAY 21 JULY 2022

United States Patent Application 20220226278
Kind Code A1
MISSLING; Christopher U. ; et al. July 21, 2022
OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT

Abstract
The present disclosure provides genetic polymorphisms associated with an altered response of a subject to Sigma-1 receptor therapy. Also described is use of the polymorphisms to personalize treatment for subjects in need of Sigma-1 receptor therapy such as treatment of neurodevelopmental and neurodegenerative diseases and conditions.

Inventors: MISSLING; Christopher U.; (New York, NY) ; AFSHAR; Mohammad Michel; (Paris, FR) ; PARMENTIER; Frederic; (Fresnes, FR)
Applicant:
Name ANAVEX LIFE SCIENCES CORP. New York NY US

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220220226278%22.PGNR.&OS=DN/20220226278&RS=DN/20220226278

Good luck and GOD bless,